Phathom Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 10.11 M | $63.39 M | 0.00% | 14.05% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 04/11/2025 | 7.46 M | $46.80 M | 0.00% | 10.37% |
| JENNISON ASSOCIATES LLC | 05/05/2025 | 7.04 M | $44.16 M | -0.29% | 9.79% |
| INVESCO LTD. | 05/12/2025 | 3.65 M | $22.89 M | -0.56% | 5.07% |
| CARLYLE GROUP INC. | 05/09/2025 | 3.50 M | $21.92 M | 0.00% | 4.86% |
| BLACKROCK, INC. | 05/02/2025 | 3.32 M | $20.84 M | -5.10% | 4.62% |
| VANGUARD GROUP INC | 05/09/2025 | 2.78 M | $17.42 M | -0.03% | 3.86% |
| ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 2.51 M | $15.76 M | -0.51% | 3.49% |
| NEA MANAGEMENT COMPANY, LLC | 05/14/2025 | 1.96 M | $12.29 M | 0.00% | 2.72% |
| WASATCH ADVISORS LP | 05/15/2025 | 1.70 M | $10.67 M | 9.15% | 2.36% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.45 M | $9.06 M | 40.98% | 2.01% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.20 M | $7.52 M | 140.00% | 1.67% |
| CATALYS PACIFIC, LLC | 05/14/2025 | 1.17 M | $7.32 M | 0.00% | 1.62% |
| PROPEL BIO MANAGEMENT, LLC | 05/15/2025 | 1.13 M | $7.12 M | 14.65% | 1.58% |
| MORGAN STANLEY | 05/15/2025 | 1.13 M | $7.09 M | 17.04% | 1.57% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 1.10 M | $6.92 M | 0.14% | 1.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.02 M | $6.37 M | -0.20% | 1.41% |
| STATE STREET CORP | 05/15/2025 | 901.35 K | $5.65 M | -13.33% | 1.25% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/15/2025 | 800.00 K | $5.02 B | -42.45% | 1.11% |
| WOODLINE PARTNERS LP | 05/15/2025 | 751.69 K | $4.71 M | -24.96% | 1.04% |
| SIMPLIFY ASSET MANAGEMENT INC. | 05/13/2025 | 681.94 K | $4.28 M | 17.18% | 0.95% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 596.11 K | $3.74 M | 100.00% | 0.83% |
| PRUDENTIAL FINANCIAL INC | 05/13/2025 | 568.63 K | $3.57 M | 22.72% | 0.79% |
| CITIGROUP INC | 05/12/2025 | 530.86 K | $3.33 M | 1,090.88% | 0.74% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 523.36 K | $3.28 M | 772.40% | 0.73% |
| FMR LLC | 05/12/2025 | 509.58 K | $3.20 M | -36.41% | 0.71% |
| STEPSTONE GROUP LP | 05/14/2025 | 422.09 K | $2.65 M | 0.00% | 0.59% |
| TREXQUANT INVESTMENT LP | 05/14/2025 | 398.75 K | $2.50 M | 5.31% | 0.55% |
| NORTHERN TRUST CORP | 05/13/2025 | 386.62 K | $2.42 M | -2.85% | 0.54% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 348.04 K | $2.18 M | -1.42% | 0.48% |
| MARSHALL WACE, LLP | 05/15/2025 | 314.87 K | $1.97 M | 221.08% | 0.44% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 200.69 K | $1.26 M | 47.57% | 0.28% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 187.87 K | $1.18 M | -54.43% | 0.26% |
| CITADEL ADVISORS LLC | 05/15/2025 | 179.72 K | $1.13 M | 149.59% | 0.25% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 170.28 K | $1.07 M | 2.27% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 161.14 K | $1.01 M | -31.55% | 0.22% |
| JPMORGAN CHASE & CO | 05/12/2025 | 137.39 K | $861.45 K | 0.36% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 114.54 K | $718.14 K | 11.47% | 0.16% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 107.40 K | $673.39 K | 508.22% | 0.15% |
| 05/12/2025 | 101.52 K | $636.53 K | 100.00% | 0.14% | |
| STATE OF WISCONSIN INVESTMENT BOARD | 05/15/2025 | 99.78 K | $625.60 K | -24.57% | 0.14% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 99.74 K | $625.40 K | -15.33% | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 97.33 K | $610.24 K | -79.97% | 0.14% |
| XTX TOPCO LTD | 05/08/2025 | 90.19 K | $565.50 K | 100.00% | 0.13% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 79.31 K | $497.00 K | 100.00% | 0.11% |
| SWISS NATIONAL BANK | 05/12/2025 | 73.30 K | $459.59 K | 0.00% | 0.10% |
| PENN MUTUAL ASSET MANAGEMENT, LLC | 05/13/2025 | 62.80 K | $393.77 K | 0.00% | 0.09% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 05/05/2025 | 60.06 K | $376.55 K | 185.03% | 0.08% |
| CREATIVE PLANNING | 05/15/2025 | 59.94 K | $375.81 K | 157.87% | 0.08% |
| RHUMBLINE ADVISERS | 05/29/2025 | 56.74 K | $355.74 K | 1.38% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 177 institutional investors and hedge funds held shares of Phathom Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 10.11 M
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
JENNISON ASSOCIATES LLC: 7.04 M
Invesco Ltd.: 3.65 M
Carlyle Group Inc.: 3.5 M
BlackRock, Inc.: 3.32 M
88.96% of Phathom Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.12 M shares in the last 24 months. This purchase volume represents approximately $298.03 M in transactions.